When is valacyclovir contraindicated, including in patients with hypersensitivity to valacyclovir or acyclovir and those with severe renal impairment (creatinine clearance <10 mL/min or on dialysis)?

Valacyclovir Contraindications

Valacyclovir is absolutely contraindicated in patients with clinically significant hypersensitivity reactions (including anaphylaxis) to valacyclovir, acyclovir, or any component of the formulation 1, 2.

Absolute Contraindication

• Hypersensitivity: Any patient who has demonstrated a clinically significant allergic reaction to valacyclovir or acyclovir should never receive this medication 1, 2. This includes anaphylaxis and other serious hypersensitivity reactions.

Critical Cautions (Not Absolute Contraindications, But Require Extreme Care)

While not listed as absolute contraindications in FDA labeling, the following situations warrant extreme caution and often preclude valacyclovir use:

Severe Renal Impairment

• Patients with end-stage renal disease (ESRD) or on dialysis face substantially elevated risk of neurotoxicity due to drug accumulation 3, 4
• The half-life of acyclovir extends from 2.5-3.3 hours in normal renal function to approximately 14 hours in ESRD 2
• Hemodialysis removes only about one-third of acyclovir during a 4-hour session 2
• Dose adjustment is mandatory in any degree of renal impairment 5, 2

Neurotoxicity Risk Profile

Recent evidence demonstrates that valacyclovir-induced neurotoxicity remains a significant problem even with dose adjustments:

• Manifestations include: confusion, psychomotor agitation, hallucinations, dysarthria, ataxia, coma, and psychosis 3, 6, 4, 7
• Symptoms typically appear 2-4 days after treatment initiation 3
• Neurotoxicity can occur even at "apparently safe doses" in dialysis patients 3
• Overdosing occurs in 25.1% of prescriptions for varicella/herpes zoster in patients with impaired renal function 8

Common Pitfalls to Avoid

1. Failure to adjust dose for renal function: This is the most common error, occurring in approximately 1 in 4 prescriptions for patients with renal impairment 8

2. Drug interactions increasing nephrotoxicity risk:

   • Avoid concurrent nephrotoxic medications when possible 7, 9
   • Particular caution with cyclosporine and mycophenolic acid in elderly patients with impaired kidney function 7

3. Inadequate hydration: Maintain good hydration during therapy 5

4. Missing early neurotoxicity signs: Any neurological symptoms in a patient on valacyclovir should prompt immediate acyclovir plasma concentration measurement and consideration of drug discontinuation 7

5. High-dose regimens in HIV patients: Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome has been reported with high doses (8 g/day) but not at standard HSV treatment doses 5

Practical Dosing Considerations

• Always calculate creatinine clearance before prescribing using the Cockcroft-Gault equation 2
• Women and prescriptions filled at community pharmacies show higher rates of inappropriate dosing 8
• In severe neurotoxicity cases with ESRD, emergent hemodialysis should be utilized to promote rapid drug excretion 4
• Symptoms resolve gradually after discontinuation alongside complete regression of viral lesions 3